Skip to main content

Diabetes

  • This November, Colgate Total supports Stop Diabetes movement

    NEW YORK — In support of National Diabetes Month, Colgate Total is donating $100,000 to help support Stop Diabetes, a movement launched by the American Diabetes Association to help educate and increase awareness of the link between oral health and diabetes.

  • IDF: 1-in-10 adults will have diabetes by 2030

    BRUSSELS — In line with World Diabetes Day, which was held Nov. 14, the International Diabetes Foundation projected that the number of people in the world living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030.

    IDF said the statistic equates to approximately three new cases every 10 seconds, or almost 10 million per year. The organization also estimated that as many as 183 million people are unaware that they have diabetes.

    The figures were released in the fifth edition of IDF's Diabetes Atlas.

  • DSN From The Blogs: Ideas are your products, too

    NEW YORK — Ideas are just as important to a winning company’s overall success as the products and services it sells. So, what’s your company doing to create a culture where the ideas that create your products and services are as important as the products themselves? That’s the question Dan Mack — EVP strategic business development for The Swanson Group and founder of the Mack Elevation Forum — puts to DrugStoreNews.com users in a hot, new content feature that debuted this week on DrugStoreNews.com.

  • Glooko cable, app allow users to download blood-glucose data to iPhone

    NEW YORK — A new app for the iPhone allows users to keep track of their blood-sugar levels on a daily basis, according to published reports.

    Glooko has launched the logbook app and MeterSync cable, which allow patients to automatically download data from their blood-glucose meters to their iPhones, add notes and send results to their healthcare providers.

    The cable costs $40 and works with popular glucose meters made by Bayer, FreeStyle and OneTouch.

  • Study: Exenatide may tout anti-inflammatory effect

    BUFFALO, N.Y. — A drug commonly prescribed to Type 2 diabetics to improve blood-sugar control also may have a rapid anti-inflammatory effect, according to results from a small study conducted by researchers at the University of Buffalo.

  • Research: Tears being examined as a pain-free way to measure glucose levels

    WASHINGTON — Scientists are reporting development and successful laboratory testing of an electrochemical sensor device that has the potential to measure blood-sugar levels from tears instead of blood — an advance that could save diabetes patients the discomfort of pricking their fingers for droplets of blood used in traditional blood-sugar tests.

  • Pawlenty and ‘who’s who’ of retail pharmacy headline 13th annual Issues Summit

    NEW YORK — CVS/pharmacy. Rite Aid. Walgreens. Sam’s Club. Ahold. H-E-B. The Katz Group. Giant Eagle. Good Neighbor. Health Mart. The list of participating companies in the 13th Annual Drug Store News Group Industry Issues conference — which will be held Tuesday, Nov. 29, here at the highly prestigious New York Athletic Club — reads like a “who’s who” of pharmacy retailing.

  • Women more receptive to diabetes education, Rite Aid survey finds

    CAMP HILL, Pa. — Women, more often than men, reported that diabetes had a greater negative impact on their emotional outlook as well as their compliance with diet and exercise recommendations, according to a study released Thursday by Rite Aid and WebMD. The survey also found that women were more open than men to receiving tools to help them manage their diabetes.

X
This ad will auto-close in 10 seconds